92 related articles for article (PubMed ID: 9330436)
1. Persistence of hemostatic alterations in patients affected by Crohn's disease after bowel surgery.
Chiarantini E; Valanzano R; Liotta AA; Cellai AP; Ilari I; Prisco D; Antonucci E; Tonelli F; Abbate R
Thromb Res; 1997 Sep; 87(6):539-46. PubMed ID: 9330436
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic abnormalities in inflammatory bowel disease.
Chiarantini E; Valanzano R; Liotta AA; Cellai AP; Fedi S; Ilari I; Prisco D; Tonelli F; Abbate R
Thromb Res; 1996 Apr; 82(2):137-46. PubMed ID: 9163067
[TBL] [Abstract][Full Text] [Related]
3. Serological Assessment of the Quality of Wound Healing Processes in Crohn's Disease.
Sun S; Karsdal MA; Mortensen JH; Luo Y; Kjeldsen J; Krag A; Jensen MD; Bay-Jensen AC; Manon-Jensen T
J Gastrointestin Liver Dis; 2019 Jun; 28():175-182. PubMed ID: 31204415
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of factor XIII levels in Crohn's disease.
Cougard PA; Desjeux A; Vitton V; Baumstarck-Barrau K; Lesavre N; Grimaud JC
J Crohns Colitis; 2012 Jul; 6(6):660-4. PubMed ID: 22398040
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
6. Hemostasis in Crohn's disease: low factor XIII levels in active disease.
Wisén O; Gardlund B
Scand J Gastroenterol; 1988 Oct; 23(8):961-6. PubMed ID: 3201134
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Inflammation on Fibrinogen Turnover and Redistribution of the Hemostatic Balance to a Prothrombotic State in High On-Treatment Platelet Reactivity-Dual Poor Responder (HTPR-DPR) Patients.
Biolik G; Gajniak D; Kubicz M; Ziaja D; Ziaja K; Kuczmik W
Mediators Inflamm; 2019; 2019():3767128. PubMed ID: 31396017
[TBL] [Abstract][Full Text] [Related]
8. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.
Voudoukis E; Karmiris K; Oustamanolakis P; Theodoropoulou A; Sfiridaki A; Paspatis GA; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1212-6. PubMed ID: 23839158
[TBL] [Abstract][Full Text] [Related]
9. Ulcerative colitis and Crohn's disease: factor XIII, inflammation and haemostasis.
Seitz R; Leugner F; Katschinski M; Immel A; Kraus M; Egbring R; Göke B
Digestion; 1994; 55(6):361-7. PubMed ID: 7705548
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation in pediatric patients with Crohn's disease.
Bernhard H; Deutschmann A; Leschnik B; Schweintzger S; Novak M; Hauer A; Muntean W
Inflamm Bowel Dis; 2011 Nov; 17(11):2333-9. PubMed ID: 21287673
[TBL] [Abstract][Full Text] [Related]
11. Differential behavior of coagulation factor XIII in patients with inflammatory bowel disease and in patients with giant cell arteritis.
Vrij AA; Rijken J; van Wersch JW; Stockbrügger RW
Haemostasis; 1999; 29(6):326-35. PubMed ID: 10844406
[TBL] [Abstract][Full Text] [Related]
12. Significance of diminished factor XIII in Crohn's disease.
Chamouard P; Grunebaum L; Wiesel ML; Sibilia J; Coumaros G; Wittersheim C; Baumann R; Cazenave JP
Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457
[TBL] [Abstract][Full Text] [Related]
13. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
14. Plateletcrit: a sensitive biomarker for evaluating disease activity in Crohn's disease with low hs-CRP.
Tang J; Gao X; Zhi M; Zhou HM; Zhang M; Chen HW; Yang QF; Liang ZZ
J Dig Dis; 2015 Mar; 16(3):118-24. PubMed ID: 25565427
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
Latella G; Cocco A; Angelucci E; Viscido A; Bacci S; Necozione S; Caprilli R
Dig Liver Dis; 2009 Apr; 41(4):269-76. PubMed ID: 18955023
[TBL] [Abstract][Full Text] [Related]
16. Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
Takeyama H; Mizushima T; Iijima H; Shinichiro S; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
Dig Dis Sci; 2015 Nov; 60(11):3418-23. PubMed ID: 26077975
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of coagulation factor XIII in Crohn's disease--establishment of a novel monoclonal anti-coagulation factor XIII antibody].
Ayabe T; Ashida T; Taruishi M; Saito Y; Murakami M; Obara T; Shibata Y; Namiki M
Nihon Shokakibyo Gakkai Zasshi; 1992 Jan; 89(1):28-35. PubMed ID: 1560594
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616
[TBL] [Abstract][Full Text] [Related]
19. Factor XIII subunits in relation to some other hemostatic parameters in ulcerative colitis.
Stadnicki A; Kloczko J; Nowak A; Sierka E; Sliwiński Z
Am J Gastroenterol; 1991 Jun; 86(6):690-3. PubMed ID: 2038990
[TBL] [Abstract][Full Text] [Related]
20. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery.
Blome M; Isgro F; Kiessling AH; Skuras J; Haubelt H; Hellstern P; Saggau W
Thromb Haemost; 2005 Jun; 93(6):1101-7. PubMed ID: 15968395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
